Indian drug makers wary as US FDA sharpens focus on quality controlPost published:May 16, 2017Post category:Industry NewsThe US FDA has increased the frequency of its inspections but also intensified scrutiny on drug manufacturing facilities in India Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostFacebook’s Sheryl Sandberg urges family-friendly policies on Mother’s Day Next PostLithium supply may be key to government’s electric vehicles push You Might Also Like Lehman Brothers, Citigroup settle $2 billion financial crisis-era dispute September 30, 2017 Steel ministry proposes scrap-based steel plants October 14, 2017 Siemens announces launch of Sirius 3RW55 Failsafe and Sirius 3RW50 soft starters November 7, 2019